Angela DiMango
Columbia University
15 Papers
64 Citations
Angela DiMango is an academic researcher from Columbia University. The author has contributed to research in topics: Bronchiectasis & Medicine. The author has an hindex of 6, co-authored 12 publications. Previous affiliations of Angela DiMango include North Shore-LIJ Health System.
Chat about Author
Papers
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry
Emily Henkle,Timothy R. Aksamit,Alan F. Barker,Jeffrey R. Curtis,Charles L. Daley,M. Leigh Anne Daniels,Angela DiMango,Edward Eden,Kevin P. Fennelly,David E. Griffith,Margaret M. Johnson,Michael R. Knowles,Amy Leitman,Philip Leitman,Elisha Malanga,Mark L. Metersky,Peadar G. Noone,Anne E. O'Donnell,Kenneth N. Olivier,Delia Prieto,Matthias Salathe,Byron Thomashow,Gregory Tino,Gerard M. Turino,Susan Wisclenny,Kevin L. Winthrop +25 more
TL;DR: ICS use was common in two national samples of patients with Bronchiectasis, with relatively few patients taking suppressive antibiotic therapies, and further research is needed to clarify the safety and effectiveness of these therapies in patients with bronchiECTasis.
46
The Clinical Features of Bronchiectasis Associated with Alpha-1 Antitrypsin Deficiency, Common Variable Immunodeficiency and Primary Ciliary Dyskinesia--Results from the U.S. Bronchiectasis Research Registry.
Edward Eden,Radmila Choate,Alan F. Barker,Doreen Addrizzo-Harris,Timothy R. Aksamit,Charles L. Daley,M. Leigh Anne Daniels,Angela DiMango,Kevin P. Fennelly,David E. Griffith,Margaret M. Johnson,Michael R. Knowles,Mark L. Metersky,Peadar G. Noone,Anne E. O'Donnell,Kenneth N. Olivier,Matthias Salathe,Andreas Schmid,Byron Thomashow,Gregory Tino,Gerard M. Turino,Kevin L. Winthrop +21 more
TL;DR: The group with PCD had more symptoms, greater morbidity, lower lung function and more commonly were infected by Pseudomonas aeruginosa compared to other groups, and a greater proportion of them reported having exacerbations and/or hospitalizations in the past 2 years.
Airway Clearance Techniques in Bronchiectasis: Analysis from the United States Bronchiectasis and Non-TB Mycobacteria Research Registry
Ashwin Basavaraj,Radmila Choate,Doreen Addrizzo-Harris,Timothy R. Aksamit,Alan F. Barker,Charles L. Daley,M. Leigh Anne Daniels,Edward Eden,Angela DiMango,Kevin P. Fennelly,David E. Griffith,Margaret M. Johnson,Michael R. Knowles,Mark L. Metersky,Peadar G. Noone,Anne E. O'Donnell,Kenneth N. Olivier,Matthias Salathe,Andreas Schmid,Byron Thomashow,Gregory Tino,Kevin L. Winthrop +21 more
TL;DR: In this paper, the authors used unadjusted and adjusted multinomial logistic regression models to assess the relationship between airway clearance techniques and clinical outcomes in patients with bronchiectasis and a productive cough.
36
Lung-volume reduction surgery for pulmonary emphysema: Improvement in body mass index, airflow obstruction, dyspnea, and exercise capacity index after 1 year.
David J. Lederer,Byron Thomashow,Mark E. Ginsburg,John H. M. Austin,Matthew N. Bartels,Chun K. Yip,Patricia A. Jellen,Frances L. Brogan,Steven M. Kawut,Roger A. Maxfield,Angela DiMango,Paul F. Simonelli,Lyall A. Gorenstein,Gregory D.N. Pearson,Joshua R. Sonett +14 more
TL;DR: Lung-volume reduction surgery for pulmonary emphysema improved the BODE index in patients with predominantly upper-lobe disease, and lower preoperative 6-minute walk distance and lower postwalk Borg fatigue scores were associated with greater improvement in the Bode index after 1 year.
31
Lung Volume Reduction Surgery Using the NETT Selection Criteria
Mark E. Ginsburg,Byron Thomashow,Chun K. Yip,Angela DiMango,Roger A. Maxfield,Matthew N. Bartels,Patricia A. Jellen,William A. Bulman,David J. Lederer,Francis L. Brogan,Lyall A. Gorenstein,Joshua R. Sonett +11 more
TL;DR: Surgical lung volume reduction for emphysema can be performed in patients using selection criteria developed by the NETT with very low surgical risk and excellent midterm results.
30